Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company BiOrion Technologies B.V.
DescriptionPlatelet derived growth factor receptor B (PDGFRB; PDGFR1; CD140B) targeted kinase inhibitor
Molecular Target Platelet derived growth factor receptor B (PDGFRB) (PDGFR1) (CD140B)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationLiver cancer
Indication DetailsTreat hepatocellular cancer (HCC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today